MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation

Tight control of p63 protein levels must be achieved under differentiation or apoptotic conditions. Here, we describe a new regulatory pathway for the ΔNp63α protein. We found that MDM2 binds ΔNp63α in the nucleus promoting its translocation to the cytoplasm. The MDM2 nuclear localization signal is required for ΔNp63α nuclear export and subsequent degradation, whereas the MDM2 ring-finger domain is dispensable. Once exported to the cytoplasm by MDM2, p63 is targeted for degradation by the Fbw7 E3-ubiquitin ligase. Efficient degradation of ΔNp63α by Fbw7 (also known as FBXW7) requires GSK3 kinase activity. By deletion and point mutations analysis we have identified a phosphodegron located in the α and β tail of p63 that is required for degradation. Furthermore, we show that MDM2 or Fbw7 depletion inhibits degradation of endogenous ΔNp63α in cells exposed to UV irradiation, adriamycin and upon keratinocyte differentiation. Our findings suggest that following DNA damage and cellular differentiation MDM2 and Fbw7 can cooperate to regulate the levels of the pro-proliferative ΔNp63α protein.

[1]  Antonio Costanzo,et al.  A p38-dependent pathway regulates ΔNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes , 2005, Oncogene.

[2]  Rob Pieters,et al.  FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors , 2007, The Journal of experimental medicine.

[3]  T. Hupp,et al.  p63: The Phantom of the Tumor Suppressor , 2007, Cell cycle.

[4]  D. Lane,et al.  p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress , 2006, Cell Death and Differentiation.

[5]  L. Guerrini,et al.  Itch/AIP4 Associates with and Promotes p63 Protein Degradation , 2006, Cell cycle.

[6]  J. Ericsson,et al.  Phosphorylation and Ubiquitination of the Transcription Factor Sterol Regulatory Element-binding Protein-1 in Response to DNA Binding* , 2006, Journal of Biological Chemistry.

[7]  Yusuke Nakamura,et al.  hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53 , 2003, Cancer science.

[8]  James M. Roberts,et al.  Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. , 2003, Molecular cell.

[9]  S. Fuchs.  Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor , 2005, Cancer biology & therapy.

[10]  Xinbin Chen,et al.  p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes , 2001, Oncogene.

[11]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[12]  A. Yang,et al.  Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. , 2005, Cancer cell.

[13]  C. Prives,et al.  Stxbp4 Regulates ΔNp63 Stability by Suppression of RACK1-Dependent Degradation , 2009, Molecular and Cellular Biology.

[14]  M. Scheffner,et al.  E6AP promotes the degradation of the PML tumor suppressor , 2009, Cell Death and Differentiation.

[15]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[16]  B. Wasylyk,et al.  MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis , 2000, The EMBO journal.

[17]  L. Ellisen,et al.  p63 and p73 in human cancer: defining the network , 2007, Oncogene.

[18]  N. Little,et al.  Hdmx and Mdm2 can repress transcription activation by p53 but not by p63 , 2001, Oncogene.

[19]  Yanping Zhang,et al.  Nucleocytoplasmic Shuttling of p53 Is Essential for MDM2-Mediated Cytoplasmic Degradation but Not Ubiquitination , 2003, Molecular and Cellular Biology.

[20]  L. Guerrini,et al.  Homeodomain protein Dlx3 induces phosphorylation-dependent p63 degradation , 2009, Cell cycle.

[21]  Allan Balmain,et al.  Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene , 2004, Nature.

[22]  A. Mills,et al.  p63 is the molecular switch for initiation of an epithelial stratification program. , 2004, Genes & development.

[23]  K Autio,et al.  DNA copy number losses in human neoplasms. , 1999, The American journal of pathology.

[24]  A. Dejean,et al.  C-terminal modifications regulate MDM2 dissociation and nuclear export of p53 , 2007, Nature Cell Biology.

[25]  E. Shaulian,et al.  Transcriptional repression of c-Jun's E3 ubiquitin ligases contributes to c-Jun induction by UV. , 2008, Cellular signalling.

[26]  Z. Xiao,et al.  MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. , 2005, Molecular cell.

[27]  H. Brunner,et al.  Splitting p63. , 2002, American journal of human genetics.

[28]  C. Croce,et al.  The E3 ubiquitin ligase Itch controls the protein stability of p63 , 2006, Proceedings of the National Academy of Sciences.

[29]  R. Mantovani,et al.  Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains† , 2002, Molecular and Cellular Biology.

[30]  B. Sjöström,et al.  Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck. , 2004, International journal of oncology.

[31]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[32]  T. Crook,et al.  High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? , 2000, Oncogene.

[33]  M. Dohn,et al.  p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. , 2001, Oncogene.

[34]  P. Hainaut,et al.  TP63 gene in stress response and carcinogenesis: a broader role than expected. , 2006, Bulletin du cancer.

[35]  W. Kaelin,et al.  The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. , 2005, Cancer cell.

[36]  O. Sangfelt,et al.  The Fbxw7/hCdc4 tumor suppressor in human cancer. , 2008, Cancer letters.

[37]  M. Dai,et al.  MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation , 2003, The EMBO journal.

[38]  Ronald T. Hay,et al.  The Protein Stability and Transcriptional Activity of p63α are Regulated by SUMO-1 Conjugation , 2005, Cell cycle.

[39]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[40]  A. Mills,et al.  p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation , 2006, Development.

[41]  D. Roop,et al.  Epidermal differentiation: transgenic/knockout mouse models reveal genes involved in stem cell fate decisions and commitment to differentiation. , 2002, The journal of investigative dermatology. Symposium proceedings.

[42]  B. Trink,et al.  p53 associates with and targets ΔNp63 into a protein degradation pathway , 2001 .

[43]  Moshe Oren,et al.  The p53 and Mdm2 families in cancer. , 2002, Current opinion in genetics & development.

[44]  H. Clegg,et al.  Unlocking the Mdm2-p53 loop: Ubiquitin is the key , 2008, Cell cycle.

[45]  S. Berberich,et al.  Regulation of p63 function by Mdm2 and MdmX. , 2001, DNA and cell biology.

[46]  S. Reed,et al.  FBXW7/hCDC4 is a general tumor suppressor in human cancer. , 2007, Cancer research.

[47]  E. Shaulian,et al.  Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy , 2008, Oncogene.

[48]  T. Parisi,et al.  The Human MDM2 Oncoprotein Increases the Transcriptional Activity and the Protein Level of the p53 Homolog p63* , 2002, The Journal of Biological Chemistry.

[49]  B. Trink,et al.  p53 associates with and targets Delta Np63 into a protein degradation pathway. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[51]  I. Watson,et al.  Ubiquitin and ubiquitin-like modifications of the p53 family. , 2006, Neoplasia.

[52]  G. Evan,et al.  Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. , 2007, Cancer cell.

[53]  Y Taya,et al.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.

[54]  References , 1971 .